Additional file 2: Table S2. of An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer’s disease

神经保护转录组学

Differentially expressed genes in glutamate and glutamate + candesartan groups. Differentially expressed genes between glutamate versus glutamate + candesartan (spreadsheet #2) and between glutamate v

Figshare2016-12-16 更新100

Whole transcriptome analysis of brain hippocampal tissue from SAMP8 mice and rat primary neurons treated with the Alzheimer's disease drug candidates CMS121 and J147

阿尔茨海默病药物研究

转录组分析

Alzheimer's disease (AD) drug discovery has rarely been addressed in the context of aging even though sporadic AD accounts for 99% of the cases. Phenotypic screens based upon old age-associated brain

干细胞与再生医学数据中心2022-02-20 更新60

File S1 - FLZ Alleviates the Memory Deficits in Transgenic Mouse Model of Alzheimer’s Disease via Decreasing Beta-Amyloid Production and Tau Hyperphosphorylation

阿尔茨海默病药物研究

阿尔茨海默病模型

File includes Fig. S1–S3. Figure S1. Morris water maze test of learning and memory deficits of APP/PS1 mice. (A) The latencies of mice to find the destination. (B) The number of platform crossing of m

NIAID Data Ecosystem40

Additional file 7: Table S4. of An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer’s disease

资源简介：

Additional file 7: Table S4. of An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer’s disease

资源简介：

相关数据集